Table 1.
Demographic characteristics of subjects
| Control (n = 73) | RA (n = 43) | IBD (n = 42) | |
|---|---|---|---|
| Age, y | 51 ± 10 | 55 ± 11 | 50 ± 10 |
| Male, % | 46 | 51 | 45 |
| SBP, mmHg | 118 ± 14 | 126 ± 13* | 125 ± 17 |
| DBP, mmHg | 67 ± 10 | 74 ± 9** | 74 ± 10** |
| Body mass index, kg/m2 | 25.6 ± 3.8 | 28.1 ± 5.8* | 26.9 ± 6.1 |
| Waist, cm | 88.2 ± 11.7 | 96.0 ± 15.5* | 92.3 ± 14.3 |
| Diabetes, % | 10 | 14 | 10 |
| Total cholesterol, mmol/L | 5.45 ± 0.86 | 5.30 ± 1.13 | 5.23 ± 1.20 |
| LDL-C, mmol/L | 3.45 ± 0.81 | 3.25 ± 1.12 | 3.19 ± 1.15 |
| HDL-C, mmol/L | 1.50 ± 0.33 | 1.44 ± 0.37 | 1.46 ± 0.45 |
| Triglycerides, mmol/L | 0.9 (0.7, 1.4) | 1.30 (0.9, 1.6)** | 1.0 (0.7, 1.7) |
| Never/ex/current smokers, % | 77/19/4 | 40/34/26*** | 28/52/20*** |
| Anti-HT treatment, % | 8 | 37*** | 9## |
| LLT, % | 4 | 11 | 5 |
| FBS, mmol/L | 4.8 (4.5, 5.2) | 4.9 (4.5, 5.4) | 4.6 (4.4, 5.2) |
| FRS | 2.0 (0, 4.5) | 4.0 (1.0, 12.0)** | 2.0 (0, 8.0) |
Results were expressed as mean ± SD, or percentage or median (25, 75 percentile). *,**,*** vs. control p < 0.05, <0.01, <0.001, respectively, ##, vs. RA p < 0.01. Anti-HT treatment: anti-hypertensive treatment; ex-smoker: prior smokers who have not smoked in the last 12 months; DBP: diastolic blood pressure; FBS: fasting blood sugar; FRS: Framingham Risk Score; HDL-C: high-density lipoprotein cholesterol; IBD: inflammatory bowel disease; LDL-C: low-density lipoprotein cholesterol; LLT: lipid-lowering therapy; RA: rheumatoid arthritis; SBP: systolic blood pressure.